AK Kakkar

948 total citations
11 papers, 755 citations indexed

About

AK Kakkar is a scholar working on Internal Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, AK Kakkar has authored 11 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Internal Medicine, 5 papers in Oncology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in AK Kakkar's work include Venous Thromboembolism Diagnosis and Management (7 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). AK Kakkar is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). AK Kakkar collaborates with scholars based in United Kingdom. AK Kakkar's co-authors include GF Nash, M F Scully, Kakkar Vv, M Samama, Michiels Jj, Russel Hull, Goldhaber Sz, Jawed Fareed, Arthur A. Sasahara and K Myers and has published in prestigious journals such as Blood, The Lancet Oncology and Journal of Thrombosis and Haemostasis.

In The Last Decade

AK Kakkar

11 papers receiving 721 citations

Peers

AK Kakkar
Ella Grilz Austria
Serdar Soyuer Türkiye
E Grossbard United States
PN Walsh United States
M. Sinn Germany
Ella Grilz Austria
AK Kakkar
Citations per year, relative to AK Kakkar AK Kakkar (= 1×) peers Ella Grilz

Countries citing papers authored by AK Kakkar

Since Specialization
Citations

This map shows the geographic impact of AK Kakkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AK Kakkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AK Kakkar more than expected).

Fields of papers citing papers by AK Kakkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AK Kakkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AK Kakkar. The network helps show where AK Kakkar may publish in the future.

Co-authorship network of co-authors of AK Kakkar

This figure shows the co-authorship network connecting the top 25 collaborators of AK Kakkar. A scholar is included among the top collaborators of AK Kakkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AK Kakkar. AK Kakkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gent, M, et al.. (2012). A Pooled Analysis of Surgical Complications: Results from the RECORD Program.. UCL Discovery (University College London). 1 indexed citations
2.
Kakkar, AK. (2009). Low molecular weight heparin and survival in cancer. 1(9). 1 indexed citations
3.
An, Nicolaides, Jawed Fareed, AK Kakkar, et al.. (2006). Prevention and treatment of venous thromboembolism - International Consensus Statement (Guidelines according to scientific evidence). International Angiology. 25(2). 101–161. 300 indexed citations
4.
Agnelli, Giancarlo, Alexander Gallus, Samuel Z. Goldhaber, et al.. (2006). Treatment of acute, symptomatic, proximal deep vein thrombosis with the oral, direct Factor Xa inhibitor rivaroxaban (BAY 59-7939) - the ODIXa-DVT dose-ranging study. 9 indexed citations
5.
Petralia, Gloria & AK Kakkar. (2004). Antithrombotic therapy with low molecular weight heparin in cancer patients.. PubMed. 9(3). 119–24. 5 indexed citations
6.
Kakkar, AK, et al.. (2003). Oral SNAC-heparin vs. enoxaparin for preventing venous thromboembolism following total hip replacement. Journal of Thrombosis and Haemostasis. 1. P1889–P1889. 11 indexed citations
7.
Baker, Ross, C.L. Bowden, AK Kakkar, et al.. (2002). A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE).. Blood. 100(11). 13 indexed citations
8.
Nash, GF, et al.. (2002). Platelets and cancer. The Lancet Oncology. 3(7). 425–430. 296 indexed citations
9.
Nash, GF, et al.. (2001). The role of the coagulation system in tumour angiogenesis. The Lancet Oncology. 2(10). 608–613. 84 indexed citations
10.
Iqbal, Sajid, et al.. (1999). Thrombomodulin expression of primary breast cancer is a predicttor of axillary lymph node metastasis. UCL Discovery (University College London). 1 indexed citations
11.
Kakkar, AK, et al.. (1995). PERIOPERATIVE HEPARIN-THERAPY INHIBITS LATE DEATH FROM METASTATIC CANCER. International Journal of Oncology. 6(4). 885–8. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026